Keyphrases
Periostitis
100%
People Living with HIV (PLHIV)
100%
Voriconazole
100%
Tenofovir
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Abacavir
100%
Coagulation
100%
Platelet Reactivity
100%
Lipids
28%
Thromboelastography
28%
Myocardial Infarction
28%
Treatment Effect
28%
Multiplate
28%
Intraindividual Differences
28%
Bone Scintigraphy
20%
Older Men
20%
Patient Symptoms
20%
Therapeutic Range
20%
Influenza
20%
Bone SPECT
20%
Diagnostic Image
20%
Isavuconazole
20%
Invasive Aspergillosis
20%
Alkaline Phosphatase
20%
SPECT-CT
20%
Skeletal Pain
20%
Fibrinolysis
14%
Functional Assay
14%
Creatinine
14%
Endothelium
14%
Endothelial Activation
14%
CD8 Count
14%
Coagulation Factor II
14%
Endothelial Damage
14%
Inflammation
14%
Secondary Hemostasis
14%
Treatment Order
14%
Primary Hemostasis
14%
HIV Patients
14%
Wilcoxon Rank Sum Test
14%
Investigator-initiated
14%
Soluble CD40 Ligand
14%
Endothelial Inflammation
14%
Hemostatic System
14%
Tenofovir Disoproxil Fumarate
14%
Coagulant
14%
Causative Mechanism
14%
HIV RNA
14%
Endothelial Disruption
14%
New Regimen
14%
Pharmacology, Toxicology and Pharmaceutical Science
Abacavir
100%
Tenofovir
100%
HIV
100%
Periostitis
100%
Voriconazole
100%
Biological Marker
57%
CD8 Antigen
28%
Inflammation
28%
Heart Infarction
28%
Alkaline Phosphatase
20%
Invasive Aspergillosis
20%
Symptom
20%
Isavuconazole
20%
Hemostatic Agent
14%
Creatinine
14%
Prothrombin
14%
Blood Clotting Factor
14%
Blood Stasis
14%
Procoagulant
14%
Tenofovir Disoproxil
14%
Thrombomodulin
14%
Biochemistry, Genetics and Molecular Biology
Abacavir
100%
Platelet Reactivity
100%
Tenofovir
100%
Human Immunodeficiency Virus 1
100%
Thromboelastography
28%
Lipid
28%
Human Immunodeficiency Virus
28%
Blood Coagulation Factor
14%
CD8 Lymphocyte Count
14%
CD8
14%
Hemostasis
14%
Thrombomodulin
14%
CD4
14%
RNA
14%
Creatinine
14%
Mann-Whitney U Test
14%
Thrombocyte Activation
14%
Fibrinolysis
14%
